The core activity of InnoMedica is the development and production of nanotransport systems for the pharmaceutical industry, particularly for oncology, neurology and immunology. The company focuses on researching and developing nanocarriers that can release active ingredients in a targeted manner in the body, aiming to achieve improved efficacy with reduced side effects. Production takes place in its own GMP-certified nanofactory, which covers the entire value chain from raw material production to final product manufacturing.